Literature DB >> 17626064

Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis.

Anil Tapisiz1, Nursen Belet, Ergin Ciftçi, Erdal Ince, Ulker Dogru.   

Abstract

Visceral leishmaniasis (VL), is a systemic disease caused by the dissemination of protozoan parasite Leishmania throughout the reticuloendothelial system. It may mimic or lead to several types of hematological disorders including hemophagocytosis. Infection associated hemophagocytic syndrome implicating Leishmania is very rare and often difficult to diagnose. Here, we describe a child with hemophagocytic lymphohistiocytosis (HLH) associated with VL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626064     DOI: 10.1093/tropej/fmm024

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  5 in total

Review 1.  Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management.

Authors:  C Gholam; S Grigoriadou; K C Gilmour; H B Gaspar
Journal:  Clin Exp Immunol       Date:  2011-03       Impact factor: 4.330

2.  Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis in late adulthood.

Authors:  Guilherme Grossi Lopes Cançado; Guilherme Gomes Freitas; Flavia Helena Fidelis Faria; Antonio Vaz de Macedo; Vandack Nobre
Journal:  Am J Trop Med Hyg       Date:  2013-01-16       Impact factor: 2.345

Review 3.  Understanding organ dysfunction in hemophagocytic lymphohistiocytosis.

Authors:  Caroline Créput; Lionel Galicier; Sophie Buyse; Elie Azoulay
Journal:  Intensive Care Med       Date:  2008-04-22       Impact factor: 41.787

Review 4.  Hemophagocytic lymphohistiocytosis: review of etiologies and management.

Authors:  Melissa R George
Journal:  J Blood Med       Date:  2014-06-12

5.  Comparison of the clinical features and outcome of children with hemophagocytic lymphohistiocytosis (HLH) secondary to visceral leishmaniasis and primary HLH: a single-center study.

Authors:  Mahdi Shahriari; Mohammadreza Bordbar; Hadi Mottaghipisheh; Kurosh Kalantar; Ali Amanati; Mansoureh Shokripour; Omid Reza Zekavat; Soheila Zareifar; Mehran Karimi; Sezaneh Haghpanah
Journal:  BMC Infect Dis       Date:  2021-08-02       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.